2023
CAR T-Related Toxicities Based on Dynamic Proteomic Profiles Identifies Risk Factors for Cytokine Release Syndrome (CRS) and Immune Effector Cell -Associated Neurotoxicity Syndrome (ICANS)
Kewan T, Mirza S, Pine A, Rasheed Y, Hamouche R, Leveille E, Goshua G, Gu S, Liu Y, Vanoudenhove J, Bar N, Neparidze N, Foss F, Gowda L, Isufi I, Halene S, Lee A, Seropian S. CAR T-Related Toxicities Based on Dynamic Proteomic Profiles Identifies Risk Factors for Cytokine Release Syndrome (CRS) and Immune Effector Cell -Associated Neurotoxicity Syndrome (ICANS). Blood 2023, 142: 2132. DOI: 10.1182/blood-2023-187295.Peer-Reviewed Original ResearchCytokine release syndromeDiffuse large B-cell lymphomaCAR T-cell therapyCAR T-cell productsCAR-T productsNon-Hodgkin lymphomaBest cutoff pointMultiple myelomaHigher oddsDay 3Risk factorsTime pointsCutoff pointDay 5Day 0Median absolute lymphocyte countChimeric antigen receptor T cellsRefractory non-Hodgkin lymphomaCAR T-cell infusionAntigen receptor T cellsLarge B-cell lymphomaCAR-T activationFludarabine/cyclophosphamideHigher baseline CRPPossible inflammatory mediators
2014
Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit
Kim R, Yao X, Longley P, Rimar J, Kournioti C, Lee A. Using the Rothman Index to Predict Discharge and Readmission Rates in an Inpatient Hematology Unit. Blood 2014, 124: 1302. DOI: 10.1182/blood.v124.21.1302.1302.Peer-Reviewed Original ResearchRothman IndexHematologic malignanciesReadmission ratesMedical recordsRA ratesYale Cancer CenterHematology-oncology patientsInpatient oncology unitCommon hematologic malignancyNon-Hodgkin lymphomaAcute myeloid leukemiaHealth care providersHealth care costsElectronic medical recordsDischarge dispositionHospitalized patientsMedian ageHematology unitHM patientsNursing assessmentOncology unitCancer CenterMultiple myelomaMyeloid leukemiaIndividual patients